{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:02:58Z","timestamp":1784563378875,"version":"3.55.0"},"reference-count":101,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Rep"],"DOI":"10.3892\/mmr.2022.12687","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T11:50:32Z","timestamp":1647517832000},"source":"Crossref","is-referenced-by-count":19,"title":["Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review)"],"prefix":"10.3892","volume":"25","author":[{"given":"Ranzhiqiang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Shakoor","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulai","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"key20220408112309_b1-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"key20220408112309_b2-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: Intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"key20220408112309_b3-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/liv.13382","article-title":"Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study","volume":"37","author":"Cucchetti","year":"2017","journal-title":"Liver Int"},{"key":"key20220408112309_b4-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/1471-2407-14-652","article-title":"The prognostic importance of jaundice in surgical resection with curative intent for gallbladder cancer","volume":"14","author":"Yang","year":"2014","journal-title":"BMC Cancer"},{"key":"key20220408112309_b5-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/cncr.29692","article-title":"Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma","volume":"122","author":"Esnaola","year":"2016","journal-title":"Cancer"},{"key":"key20220408112309_b6-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/MEG.0b013e328224b935","article-title":"Risk factors for cholangiocarcinoma","volume":"19","author":"Ben-Menachem","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20220408112309_b7-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.18632\/oncotarget.13846","article-title":"STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"key20220408112309_b8-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: New and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"key20220408112309_b9-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2017.12.003","article-title":"The role of STAT3 in leading the crosstalk between human cancers and the immune system","volume":"415","author":"Wang","year":"2018","journal-title":"Cancer Lett"},{"key":"key20220408112309_b10-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/cancers14020429","article-title":"STAT3 signaling in breast cancer: Multicellular actions and therapeutic potential","volume":"14","author":"To","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20220408112309_b11-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"key20220408112309_b12-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s43440-020-00156-5","article-title":"STAT3 transcription factor as target for anti-cancer therapy","volume":"72","author":"Mohassab","year":"2020","journal-title":"Pharmacol Rep"},{"key":"key20220408112309_b13-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","article-title":"STAT3 in the systemic inflammation of cancer cachexia","volume":"54","author":"Zimmers","year":"2016","journal-title":"Semin Cell Dev Biol"},{"key":"key20220408112309_b14-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"key20220408112309_b15-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1074\/mcp.M114.044404","article-title":"Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity","volume":"14","author":"Jin","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"key20220408112309_b16-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"110979","DOI":"10.1016\/j.mce.2020.110979","article-title":"Activating mutations of STAT3: Impact on human growth","volume":"518","author":"Guti\u00e9rrez","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"key20220408112309_b17-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","article-title":"The IL-6\/JAK\/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer (Review)","volume":"44","author":"Wang","year":"2014","journal-title":"Int J Oncol"},{"key":"key20220408112309_b18-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.3390\/ijms22126211","article-title":"Role of JAK\/STAT in interstitial lung diseases; Molecular and cellular mechanisms","volume":"22","author":"Montero","year":"2021","journal-title":"Int J Mol Sci"},{"key":"key20220408112309_b19-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0772-7","article-title":"JAK-STAT Signaling as a target for inflammatory and autoimmune diseases: Current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"key20220408112309_b20-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"key20220408112309_b21-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1478-3231.2006.01254.x","article-title":"Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways","volume":"26","author":"Yokoyama","year":"2006","journal-title":"Liver Int"},{"key":"key20220408112309_b22-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.cellsig.2012.01.018","article-title":"The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis","volume":"24","author":"Bode","year":"2012","journal-title":"Cell Signal"},{"key":"key20220408112309_b23-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"e001946","DOI":"10.1136\/jitc-2020-001946","article-title":"Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3","volume":"9","author":"Zhou","year":"2021","journal-title":"J Immunother Cancer"},{"key":"key20220408112309_b24-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"key20220408112309_b25-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"7279","DOI":"10.1038\/srep07279","article-title":"Bipolar\/rod-shaped microglia are proliferating microglia with distinct M1\/M2 phenotypes","volume":"4","author":"Tam","year":"2014","journal-title":"Sci Rep"},{"key":"key20220408112309_b26-mmr-25-05-12687","first-page":"57","article-title":"IL-10 regulates adult neurogenesis by modulating ERK and STAT3 activity","volume":"9","author":"Leticia","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"key20220408112309_b27-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"20741","DOI":"10.18632\/oncotarget.15119","article-title":"IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2\/STAT3 signaling pathway","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"key20220408112309_b28-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1002\/art.34601","article-title":"Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells","volume":"64","author":"Ju","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key20220408112309_b29-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.amjoto.2012.07.009","article-title":"Reciprocal roles of STAT3 and STAT5 in nasal polyposis","volume":"33","author":"Wang","year":"2012","journal-title":"Am J Otolaryngol"},{"key":"key20220408112309_b30-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.clim.2014.12.012","article-title":"Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome","volume":"157","author":"Zheng","year":"2015","journal-title":"Clin Immunol"},{"key":"key20220408112309_b31-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12935-020-01687-w","article-title":"Intrahepatic cholangiocarcinoma induced M2-polarized Tumor-associated macrophages facilitate tumor growth and invasiveness","volume":"20","author":"Yuan","year":"2020","journal-title":"Cancer Cell Int"},{"key":"key20220408112309_b32-mmr-25-05-12687","first-page":"51","article-title":"Research progress of EGFR gene mutation and its detection methods","volume":"3","author":"Gao","year":"2011","journal-title":"Mol Diagn Ther"},{"key":"key20220408112309_b33-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2014.06.001","article-title":"ErbB\/HER protein-tyrosine kinases: Structures and small molecule inhibitors","volume":"87","author":"Roskoski","year":"2014","journal-title":"Pharmacol Res"},{"key":"key20220408112309_b34-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.7314\/APJCP.2014.15.14.5535","article-title":"Analysis of indoleamine 2\u20133 dioxygenase (IDO) and EGFR co-expression in breast cancer tissue by immunohistochemistry","volume":"15","author":"Bi","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20220408112309_b35-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.7314\/APJCP.2012.13.6.2873","article-title":"Expression and clinical significance of STAT3, p-STAT3, and VEGF-C in small cell lung cancer","volume":"13","author":"Zhao","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20220408112309_b36-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/cancers6010494","article-title":"Genetic Interactions of STAT3 and Anticancer Drug Development","volume":"6","author":"Fang","year":"2014","journal-title":"Cancers (Basel)"},{"key":"key20220408112309_b37-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1158\/0008-5472.CAN-03-3197","article-title":"Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis","volume":"64","author":"Chan","year":"2004","journal-title":"Cancer Res"},{"key":"key20220408112309_b38-mmr-25-05-12687","first-page":"4995","article-title":"Blocking of the EGFR-STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med"},{"key":"key20220408112309_b39-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1293\/tox.2014-0047","article-title":"Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3\u2032-methyl-4 dimethylaminoazobenzene in rats","volume":"28","author":"Zhang","year":"2015","journal-title":"J Toxicol Pathol"},{"key":"key20220408112309_b40-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/pro.2446","article-title":"Structure and function of LGR5: An enigmatic G-protein coupled receptor marking stem cells","volume":"23","author":"Kumar","year":"2014","journal-title":"Protein Sci"},{"key":"key20220408112309_b41-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2174\/138945008784911750","article-title":"WNT signaling in stem cell biology and regenerative medicine","volume":"9","author":"Katoh","year":"2008","journal-title":"Curr Drug Targets"},{"key":"key20220408112309_b42-mmr-25-05-12687","first-page":"273","article-title":"STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review)","volume":"19","author":"Katoh","year":"2007","journal-title":"Int J Mol Med"},{"key":"key20220408112309_b43-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1158\/1078-0432.CCR-06-2316","article-title":"WNT signaling pathway and stem cell signaling network","volume":"13","author":"Katoh","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20220408112309_b44-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1101\/gad.1295405","article-title":"Wnt signaling in the intestinal epithelium: From endoderm to cancer","volume":"19","author":"Gregorieff","year":"2005","journal-title":"Genes Dev"},{"key":"key20220408112309_b45-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/liv.14747","article-title":"LGR5 induces \u03b2-catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma","volume":"41","author":"Kawasaki","year":"2021","journal-title":"Liver Int"},{"key":"key20220408112309_b46-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"e88772","DOI":"10.1371\/journal.pone.0088772","article-title":"Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation","volume":"9","author":"Chung","year":"2017","journal-title":"PLoS One"},{"key":"key20220408112309_b47-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"36505","DOI":"10.1074\/jbc.274.51.36505","article-title":"Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts","volume":"274","author":"Park","year":"1999","journal-title":"J Biol Chem"},{"key":"key20220408112309_b48-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","article-title":"Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy","volume":"8","author":"Hamson","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"key20220408112309_b49-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1046\/j.1523-1747.2003.12035.x","article-title":"Fibroblast activation protein: Differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors","volume":"120","author":"Huber","year":"2003","journal-title":"J Invest Dermatol"},{"key":"key20220408112309_b50-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP Promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res"},{"key":"key20220408112309_b51-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/hep.24588","article-title":"Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells","volume":"54","author":"Fingas","year":"2011","journal-title":"Hepatology"},{"key":"key20220408112309_b52-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2353\/ajpath.2006.050204","article-title":"Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1released in stroma","volume":"168","author":"Ohira","year":"2006","journal-title":"Am J Pathol"},{"key":"key20220408112309_b53-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/hep.26585","article-title":"Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor","volume":"58","author":"Claperon","year":"2013","journal-title":"Hepatology"},{"key":"key20220408112309_b54-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jhep.2014.03.033","article-title":"EGF\/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition","volume":"61","author":"Claperon","year":"2014","journal-title":"J Hepatol"},{"key":"key20220408112309_b55-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.neo.2019.10.005","article-title":"Fibroblastic FAP promotes intrahepatic cholangiocarcinoma growth via MDSCs recruitment","volume":"21","author":"Lin","year":"2019","journal-title":"Neoplasia"},{"key":"key20220408112309_b56-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1476-4598-7-78","article-title":"Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival","volume":"7","author":"Chen","year":"2008","journal-title":"Mol Cancer"},{"key":"key20220408112309_b57-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s12094-012-0789-z","article-title":"Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is amarker of good prognosis","volume":"14","author":"Sonnenblick","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"key20220408112309_b58-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1038\/sj.onc.1205263","article-title":"Constitutive activation of Stat3alpha in brain tumors: Localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2)","volume":"21","author":"Schaefer","year":"2002","journal-title":"Oncogene"},{"key":"key20220408112309_b59-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.bjc.6605212","article-title":"Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma","volume":"101","author":"Takemoto","year":"2009","journal-title":"Br J Cancer"},{"key":"key20220408112309_b60-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1158\/1078-0432.CCR-15-1253","article-title":"The opposing function of STAT3 as an oncoprotein and tumor suppressor is dictated by the expression status of STAT3\u03b2 in esophageal squamous cell carcinoma","volume":"22","author":"Zhang","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20220408112309_b61-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.oraloncology.2015.11.022","article-title":"The STAT3 pathway as a therapeutic target in head and neck cancer: Barriers and innovations","volume":"56","author":"Geiger","year":"2016","journal-title":"Oral Oncol"},{"key":"key20220408112309_b62-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"e81657","DOI":"10.1371\/journal.pone.0081657","article-title":"Icaritin inhibits JAK\/STAT3 signaling and growth of renal cell carcinoma","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"key20220408112309_b63-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"448","DOI":"10.7150\/ijbs.11164","article-title":"Signal transducer and activator of transcription 4 in liver diseases","volume":"11","author":"Wang","year":"2015","journal-title":"Int J Biol Sci"},{"key":"key20220408112309_b64-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3892\/ijo.2014.2808","article-title":"Inhibition of IL-6\/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells","volume":"46","author":"Suh","year":"2015","journal-title":"Int J Oncol"},{"key":"key20220408112309_b65-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"45443","DOI":"10.1074\/jbc.M107527200","article-title":"Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation","volume":"276","author":"Turkson","year":"2001","journal-title":"J Biol Chem"},{"key":"key20220408112309_b66-mmr-25-05-12687","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1158\/1535-7163.261.3.3","article-title":"Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity","volume":"3","author":"Turkson","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"key20220408112309_b67-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1021\/jm2000882","article-title":"Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3","volume":"54","author":"Mandal","year":"2011","journal-title":"J Med Chem"},{"key":"key20220408112309_b68-mmr-25-05-12687","first-page":"155","article-title":"A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis","volume":"10","author":"Auzenne","year":"2012","journal-title":"J Exp TherOncol"},{"key":"key20220408112309_b69-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1038\/bcj.2013.63","article-title":"A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases","volume":"3","author":"Hayakawa","year":"2013","journal-title":"Blood Cancer J"},{"key":"key20220408112309_b70-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.canlet.2013.02.010","article-title":"OPB-31121, a novel small molecular inhibitor, disrupts the JAK2\/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells","volume":"335","author":"Kim","year":"2013","journal-title":"Cancer Lett"},{"key":"key20220408112309_b71-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00280-014-2480-2","article-title":"Phase 1, open-label, dose-escalation, and pharmacokinetic study of STAT3 inhibitor OPB-31121 in subjects with advanced solid tumors","volume":"74","author":"Bendell","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20220408112309_b72-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"607","DOI":"10.4143\/crt.2014.249","article-title":"Phase I study of OPB-31121, an oral STAT3 inhibitor, in patients with advanced solid tumors","volume":"47","author":"Oh","year":"2015","journal-title":"Cancer Res Treat"},{"key":"key20220408112309_b73-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/hepr.12504","article-title":"Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma","volume":"45","author":"Okusaka","year":"2015","journal-title":"Hepatol Res"},{"key":"key20220408112309_b74-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/annonc\/mdv026","article-title":"Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies","volume":"26","author":"Wong","year":"2015","journal-title":"Ann Oncol"},{"key":"key20220408112309_b75-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/cas.12683","article-title":"Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed\/refractory hematological malignancies","volume":"106","author":"Ogura","year":"2015","journal-title":"Cancer Sci"},{"key":"key20220408112309_b76-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"26307","DOI":"10.18632\/oncotarget.8368","article-title":"Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma","volume":"7","author":"Bharadwaj","year":"2016","journal-title":"Oncotarget"},{"key":"key20220408112309_b77-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/sj.onc.1208316","article-title":"In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: Implications for cancer therapy","volume":"24","author":"Xi","year":"2005","journal-title":"Oncogene"},{"key":"key20220408112309_b78-mmr-25-05-12687","first-page":"237","article-title":"Inhibitory effects of decoy-ODN targeting activated STAT3 on human glioma growth in vivo","volume":"23","author":"Shen","year":"2009","journal-title":"In Vivo"},{"key":"key20220408112309_b79-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.imbio.2005.11.004","article-title":"An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer","volume":"211","author":"Sun","year":"2006","journal-title":"Immunobiology"},{"key":"key20220408112309_b80-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1471-2407-7-149","article-title":"Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice","volume":"7","author":"Zhang","year":"2007","journal-title":"BMC Cancer"},{"key":"key20220408112309_b81-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3892\/ijmm.2013.1431","article-title":"Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo","volume":"32","author":"Zhang","year":"2013","journal-title":"Int J Mol Med"},{"key":"key20220408112309_b82-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1172\/JCI200421032","article-title":"Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis","volume":"114","author":"Chan","year":"2004","journal-title":"J Clin Invest"},{"key":"key20220408112309_b83-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1182\/blood-2015-08-665604","article-title":"Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"key":"key20220408112309_b84-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2741\/4374","article-title":"Role of the tumor microenvironment in pancreatic adenocarcinoma","volume":"21","author":"Sun","year":"2016","journal-title":"Front Biosci (Landmark Ed)"},{"key":"key20220408112309_b85-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.02.005","article-title":"Tumor regulation of the tissue environment in the liver","volume":"173","author":"Eggert","year":"2017","journal-title":"Pharmacol Ther"},{"key":"key20220408112309_b86-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1245\/s10434-010-1458-5","article-title":"Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: A possible role of hepatitis B virus","volume":"18","author":"Peng","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"key20220408112309_b87-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1747-1028-5-14","article-title":"Stat3: Linking inflammation to epithelial cancer-more than a \u2018gut\u2019 feeling?","volume":"5","author":"Jarnicki","year":"2010","journal-title":"Cell Div"},{"key":"key20220408112309_b88-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"e12974","DOI":"10.1111\/cpr.12974","article-title":"STAT3 and its targeting inhibitors in osteosarcoma","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif"},{"key":"key20220408112309_b89-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2003-06-2151","article-title":"Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis","volume":"103","author":"Bharti","year":"2004","journal-title":"Blood"},{"key":"key20220408112309_b90-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1038\/sj.onc.1207606","article-title":"STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells","volume":"23","author":"Kanda","year":"2004","journal-title":"Oncogene"},{"key":"key20220408112309_b91-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.1158\/1078-0432.CCR-05-0827","article-title":"Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer","volume":"11","author":"Haura","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20220408112309_b92-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/MLG.0b013e31817fd3fa","article-title":"Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas","volume":"118","author":"Liu","year":"2008","journal-title":"Laryngoscope"},{"key":"key20220408112309_b93-mmr-25-05-12687","first-page":"e23828","article-title":"Targeting the tumor microenvironment: JAK-STAT3 signaling","volume":"2","author":"Bournazou","year":"2013","journal-title":"JAKSTAT"},{"key":"key20220408112309_b94-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc1275","article-title":"The STATs of cancer-new molecular targets come of age","volume":"4","author":"Yu","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"key20220408112309_b95-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.jhep.2016.02.004","article-title":"IL-6 pathway in the liver: From physiopathology to therapy","volume":"64","author":"Schmidt-Arras","year":"2016","journal-title":"J Hepatol"},{"key":"key20220408112309_b96-mmr-25-05-12687","first-page":"207","article-title":"Effect of small interfering RNA targeting p63 on the proliferation and invasiveness of human cholangiocarcinoma cells in vitro","volume":"32","author":"Liu","year":"2012","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20220408112309_b97-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1038\/onc.2012.617","article-title":"Intrahepatic cholangiocarcinoma: Pathogenesis and rationale for molecular therapies","volume":"32","author":"Sia","year":"2013","journal-title":"Oncogene"},{"key":"key20220408112309_b98-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J Hepatol"},{"key":"key20220408112309_b99-mmr-25-05-12687","first-page":"5","article-title":"Effects of STAT3 on proliferation and apoptosis of human intrahepatic bile duct carcinoma cells","volume":"55","author":"Liu","year":"2015","journal-title":"Shandong Med J"},{"key":"key20220408112309_b100-mmr-25-05-12687","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","article-title":"Recent update on development of Small-Molecule STAT3 inhibitors for cancer therapy: From phosphorylation inhibition to protein degradation","volume":"64","author":"Dong","year":"2021","journal-title":"J Med Chem"},{"key":"key20220408112309_b101-mmr-25-05-12687","first-page":"809","article-title":"MicroRNA-7-5p Inhibits Migration, Invasion and Metastasis of Intrahepatic Cholangiocarcinoma by Inhibiting MyD88","volume":"9","author":"Tang","year":"2021","journal-title":"J Clin Transl Hepatol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T10:38:55Z","timestamp":1674988735000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2022.12687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":101,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3,17]]}},"URL":"https:\/\/doi.org\/10.3892\/mmr.2022.12687","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"article-number":"171"}}